PYSZCZYMUKA GREG
SEC CIK 1952920 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AYTU | AYTU BIOPHARMA, INC | Chief Commerical Off | 56.1K | $46.4K | — | 13 | 2022-12-19 | 2026-07-28 |
Most active insiders at AYTU, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | JAIN ABHINAV | Dir | — | — |
| 2 | PYSZCZYMUKA GREG | Chief Commercial Off | — | — |
| 3 | Donofrio John Jr. | Dir | — | — |
| 4 | Selhorn Ryan J | CFO | — | — |
| 5 | Disbrow Jarrett | Chief Business Off | — | — |
| 6 | DOCKERY CARL | Dir | — | — |
| 7 | Disbrow Joshua R. | CEO, Dir | — | — |
| 8 | LIU VIVIAN H | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 16:34 | 2026-07-28 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | A - Grant | $0.00 | +20.0K | 56.1K | +55% | $0 | |
| 2025-10-07 | 2025-10-03 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | A - Grant | $0.00 | +12.5K | 36.1K | +53% | $0 | |
| D | 2025-03-31 | 2025-03-31 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | M - OptEx | — | +209 | 23.6K | +0.9% | — |
| D | 2025-01-02 | 2024-12-31 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | M - OptEx | — | +208 | 23.4K | +0.9% | — |
| D | 2024-10-02 | 2024-09-30 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | M - OptEx | — | +209 | 23.2K | +0.9% | — |
| D | 2024-07-02 | 2024-06-30 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | M - OptEx | — | +208 | 23.0K | +0.9% | — |
| D | 2024-04-02 | 2024-03-31 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | M - OptEx | — | +208 | 22.8K | +0.9% | — |
| D | 2024-01-02 | 2023-12-31 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | M - OptEx | — | +209 | 22.6K | +0.9% | — |
| D | 2023-10-03 | 2023-09-30 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | M - OptEx | — | +208 | 22.4K | +0.9% | — |
| D | 2023-07-06 | 2023-06-30 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commerical Off | M - OptEx | — | +208 | 22.1K | +0.9% | — |
| D | 2023-06-20 | 2023-04-25 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commerical Off | M - OptEx | $0.00 | +833 | 9,935 | +9% | $0 |
| 2023-06-20 | 2023-06-16 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commerical Off | P - Purchase | $1.87 | +12.0K | 21.9K | +121% | +$22.4K | |
| 2022-12-21 | 2022-12-19 | AYTU | AYTU BIOPHARMA, INC | PYSZCZYMUKA GREG | Chief Commercial Off | P - Purchase | $0.24 | +100.0K | 182.1K | +122% | +$24.0K |
Purchase Sale Sale after option exercise All abbreviations